Similar articles

• Managing benign prostatic hyperplasia.

  Garnett S, Abrams P. Garnett S, et al. Practitioner. 2001 Oct;245(1627):830-2, 834, 836 passim. Practitioner. 2001. PMID: 11677898 Review. No abstract available.
• Assessment of the patient with benign prostatic hyperplasia.

  Carlin BI, Resnick ML. Carlin BI, et al. Compr Ther. 1996 Sep;22(9):586-91. Compr Ther. 1996. PMID: 8902350 Review. No abstract available.
• [Treatment of benign prostate hyperplasia].

  Romics I. Romics I. Orv Hetil. 2010 Mar 21;151(12):506-8. doi: 10.1556/OH.2010.28809. Orv Hetil. 2010. PMID: 20231135 Hungarian. No abstract available.
• [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].

  Hausmann R, Thalmann G, Reich O, Steif CG. Hausmann R, et al. Aktuelle Urol. 2004 Sep;35(5):339-42. doi: 10.1055/s-2004-834352. Aktuelle Urol. 2004. PMID: 15383991 German. No abstract available.
• [Benign prostatic hyperplasia: variability in practice and guide to action based on scientific evidence].

  Baile A, Asua J, Albisu A. Baile A, et al. Aten Primaria. 1999 Feb 28;23(3):142-50. Aten Primaria. 1999. PMID: 10095285 Review. Spanish. No abstract available.